Replies to post #679233 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

So then why the need to alter the endpoint?
All they had to do was examine the progress as psPD alleviated, right?

One would then think that the only reason to change the endpoint was due to a failed trial.... Am I correct?